QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 发表日期：2019     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial 期刊论文 JOURNAL OF THORACIC ONCOLOGY, 2019, 卷号: 14, 期号: 5 作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie 收藏  |  浏览/下载：31/0  |  提交时间：2019/12/05 Chinese population  Nivolumab  NSCLC  Phase III clinical study   Development of biodegradable polyesters based on a hydroxylated coumarin initiator towards fluorescent visible paclitaxel-loaded microspheres 期刊论文 JOURNAL OF MATERIALS CHEMISTRY B, 2019, 卷号: 7, 页码: 2261-2276 作者:  Bian, Yufei;  Wei, Zhiyong;  Wang, Zefeng;  Tu, Zhu;  Zheng, Liuchun 收藏  |  浏览/下载：25/0  |  提交时间：2019/12/02 Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced Non-Small Cell Lung Cancer: CheckMate 078 Randomized Phase III Clinical Trial 期刊论文 Journal of Thoracic Oncology, 2019 作者:  Yi-Long Wu;  Shun Lu;  Ying Cheng;  Caicun Zhou;  Jie Wang 收藏  |  浏览/下载：15/0  |  提交时间：2019/02/25 Chinese  population  nivolumab  non-small  cell  lung  cancer  phase  III  clinical  study   Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial 期刊论文 2019, 卷号: 14, 期号: 5, 页码: 867-875 作者:  Wu, Yi-Long;  Lu, Shun;  Cheng, Ying;  Zhou, Caicun;  Wang, Jie 收藏  |  浏览/下载：14/0  |  提交时间：2020/01/03 Chinese population  Nivolumab  NSCLC  Phase III clinical study